March 06, 2026 02:18 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Guest of India struck in international waters': Iran furious after US submarine torpedoes IRIS Dena | Bihar's 'Susashan Babu' Nitish Kumar announces exit as CM, set for Rajya Sabha debut | ‘Baseless’: India rejects claims US used its ports to strike Iran | Defiant silence: Iran women’s team refuses anthem days after Khamenei’s death | 'You’ll find out soon': Trump hints at massive retaliation after Riyadh attack, says ‘boots on ground’ may not be needed | Iran claims Netanyahu's office targeted in 'surprise missile attacks' | India, Canada to host renewable energy summit as Modi, Carney push to deepen bilateral ties | Gold, silver surge as Middle East conflict sparks safe-haven buying | Middle East tension: Several US warplanes crash in Kuwait, says Defence Ministry | Indian defence shares jump as West Asia conflict triggers investor rush
In images: Munh Parikshak (L) | Dhirendra Singh of Scangenie Scientific and Dean of IIT Kanpur R&D Prof. Tarun Gupta

IIT Kanpur hands over oral cancer detection device developed at institute's lab

| @indiablooms | Aug 14, 2024, at 06:27 am

Kanpur: Indian Institute of Technology Kanpur (IITK) has transferred its unique technology, 'Munh Parikshak,' a portable device for detecting oral cancer, invented by Prof. Jayant Kumar Singh and his team from the Department of Chemical Engineering, to Scangenie Scientific Pvt. Ltd.

The device uses special lights and a camera to examine the mouth, providing instant results by analysing mouth images and categorizing them as normal, pre-cancerous, or cancerous.

The results are displayed on a smartphone app and stored on cloud servers for continuous updates, making it ideal for self-testing.

Munh-Parikshak is a user-friendly device having white and fluorescence light source that connects wirelessly to smartphones, tablets, iPads, etc. With a built-in power backup, it stores health history for tracking and provides instant oral health reports.

The device offers quick and painless screening with 90% accuracy in clinical settings. It is safe, radiation-free, and does not require any additional chemicals or processes.

Prof. Manindra Agrawal, Director of IIT Kanpur, said, “IIT Kanpur is working tirelessly to drive healthcare innovation and tackle critical health issues, and I am delighted to see our innovative technology, 'Munh Parikshak,' being transferred to Scangenie Scientific Pvt. Ltd.

"I extend my heartfelt congratulations to Prof. Jayant Kumar Singh and his team for their exceptional work. Their dedication has paved the way for this collaboration, which marks a pivotal step in the early detection of oral cancer, significantly enhancing health outcomes and demonstrating the profound impact of our research on society."

Prof. Tarun Gupta, Dean of Research and Development at IIT Kanpur, remarked, “The signing of the MoU with Scangenie Scientific Pvt. Ltd. marks a significant milestone in our mission to transition research and development into commercially viable products. The institute's licensing rate has also seen an increase, which motivates us to further support research across various fields. This MoU aims to effectively market our invention within the healthcare sector, ultimately affordable and beneficial to everyone.”

According to market research findings, the oral cancer diagnosis market is expected to reach $2.98 billion by 2032 with a 5% CAGR, while the rapid test kit market, currently at $736 million, is growing at a 7% CAGR until 2027.

Oral cancer is among the top global cancers, posing economic and clinical burdens on healthcare systems worldwide, particularly impacting India, where it constitutes up to 40% of cases.

Early detection is vital to reduce morbidity and mortality, driving the need for affordable, non-invasive, user-friendly diagnostic tools for widespread screening.

Through this strategic collaboration, IIT Kanpur and Scangenie Scientific Pvt. Ltd. will advance early cancer detection technology, improving healthcare outcomes and showcasing the impact of innovative solutions.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.